With the line between food and drug blurring, the queue of such products and supplements waiting for approval is growing rapidly, a senior official at FSSAI says
Industry has opposed the government idea of implementing the change in land acquisition norms on a retrospective basis. Also, it feels the absence of details in the (draft) Bill may trigger further litigation.